2021
Trends and geographical variation in population thriving, struggling and suffering across the USA, 2008–2017: a retrospective repeated cross-sectional study
Riley C, Herrin J, Lam V, Hamar B, Witters D, Liu D, Krumholz HM, Roy B. Trends and geographical variation in population thriving, struggling and suffering across the USA, 2008–2017: a retrospective repeated cross-sectional study. BMJ Open 2021, 11: e043375. PMID: 34261676, PMCID: PMC8281074, DOI: 10.1136/bmjopen-2020-043375.Peer-Reviewed Original ResearchConceptsPercentage of peopleCross-sectional studyWell-Being IndexMarked geographical variationNational HealthRetrospective analysisUS populationCross-sectional sampleLife evaluationGeographical disparitiesGreater improvementCantril SelfCurrent life satisfactionGeographical variationLife optimismNational averageInterventionConceptions of healthHealthPercentage
2016
Population Well-Being Measures Help Explain Geographic Disparities In Life Expectancy At The County Level
Arora A, Spatz E, Herrin J, Riley C, Roy B, Kell K, Coberley C, Rula E, Krumholz HM. Population Well-Being Measures Help Explain Geographic Disparities In Life Expectancy At The County Level. Health Affairs 2016, 35: 2075-2082. PMID: 27834249, PMCID: PMC5150263, DOI: 10.1377/hlthaff.2016.0715.Peer-Reviewed Original Research
2010
Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone
Shah ND, Montori VM, Krumholz HM, Tu K, Alexander GC, Jackevicius CA. Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone. New England Journal Of Medicine 2010, 363: 2081-2084. PMID: 21083379, DOI: 10.1056/nejmp1011042.Peer-Reviewed Original Research
2008
Hospital Remoteness And Thirty-Day Mortality From Three Serious Conditions
Ross JS, Normand SL, Wang Y, Nallamothu BK, Lichtman JH, Krumholz HM. Hospital Remoteness And Thirty-Day Mortality From Three Serious Conditions. Health Affairs 2008, 27: 1707-1717. PMID: 18997230, DOI: 10.1377/hlthaff.27.6.1707.Peer-Reviewed Original ResearchConceptsRisk-standardized mortality ratesThirty-day mortalityAcute myocardial infarctionHigh-quality health careMedicare administrative dataGeographic remotenessHeart failureMyocardial infarctionSerious conditionMillions of AmericansRural U.S. communitiesMortality differencesMortality rateRural hospitalsSmaller mortality differencesHealth careAdministrative dataHospitalU.S. communitiesCareHospitalizationInfarctionPneumoniaMortality
2004
Hospital-Level Performance Improvement
Bradley EH, Herrin J, Mattera JA, Holmboe ES, Wang Y, Frederick P, Roumanis SA, Radford MJ, Krumholz HM. Hospital-Level Performance Improvement. Medical Care 2004, 42: 591-599. PMID: 15167327, DOI: 10.1097/01.mlr.0000128006.27364.a9.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAmerican Hospital AssociationCardiology Service, HospitalComorbidityDrug Utilization ReviewFemaleGeographyGuideline AdherenceHealth Care SurveysHumansLogistic ModelsMaleMiddle AgedMyocardial InfarctionPatient DischargeQuality Assurance, Health CareRegistriesSocioeconomic FactorsUnited StatesConceptsBeta-blocker useAcute myocardial infarctionHospital-level variationHospital characteristicsMyocardial infarctionBeta-blocker prescription ratesHospital-level changesHospital-level ratesAmerican Hospital Association Annual SurveyClinical characteristicsPrescription ratesNational registryAMI volumeHospital ratesRate of improvementImprovement rateTeaching statusIndividual hospitalsInfarctionHospitalNational surveyPercentage pointsTime periodUse ratesWeak predictor